Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of The Neonatal Inhaled Nitric Oxide Study Group (NINOS)

Journal of Pediatrics

Volumn 136, Issue 5, 2000, Pages 611-617

  Finer, Neil ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BRONCHODILATING AGENT; DIURETIC AGENT; NITRIC OXIDE;

ARTICLE; CEREBRAL PALSY; CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISABILITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEVELOPMENT; NEUROLOGIC DISEASE; NEWBORN; NEWBORN HYPOXIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT;

EID: 0034030710     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.104826     Document Type: Article

References (24)

1. 1. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-9.
2. 2. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
3. 3. Day RW, Lynch JM, White KS, Ward RM. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 1996;98:698-705.
4. 4. Barefield ES, Karle VA, Phillips JB III, Carlo WA. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996;129:279-86.
5. 5. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in term and near-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
6. 6. Roberts JD Jr, Fineman JR, Morin FC III, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336: 605-10.
7. 7. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn. J Pediatr 1997;131:55-62.
8. 8. Wessel DL, Adatia I, Van Marter LJ, et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1997;100:E7.
9. 9. Davidson D, Barefield ES, Kattwinkel J, et al and the INO/PPHN Study Group. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998;101:325-34.
10. 10. Finer NN, Barrington KJ. Nitric oxide therapy for the newborn infant. Semin Neonatol 1998;3:127-36.
11. 11. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997:99:838-45.
12. 12. Bayley N. Bayley Scales of Infant Development II. San Antonio, TX: Psychological Corporation; 1993.
13. 13. Amiel-Tison C. Neuromotor status. In: Taeusch HW, Yogman MW, editors. Follow-up management of the high-risk infant. Boston, MA: Little, Brown & Company; 1987. p. 115-26.
14. 14. Northern J, Downs M. Hearing in Children. Baltimore, MD: Williams and Wilkins; 1978.
15. 15. Stamler JS, Jia L, Eu JP, et al. Blood flow regulation by s-nitrosohemoglobin in the physiological oxygen gradient. Science 1997;276:2034-37.
16. 16. Rosenberg AA, Kennaugh JM, Moreland SG, et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 1997;131:70-5.
17. 17. Clark RH, Yoder BA, Sell MS. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994;124:447-54.
18. 18. UK Collaborative ECMO Group. The collaborative UK ECMO trial: follow-up to 1 year of age. Pediatrics 1998; 101:690:E1.
19. 19. Barabas RE, Barmada MA, Scher MS. Timing of brain insults in severe neonatal encephalopathies with isoelectric EEC. Pediatr Neurol 1993;9:39-44.
20. 20. Cheung PY, Haluschak MM, Finer NN, Robertson CM. Sensorineural hearing loss in survivors of neonatal extracorporeal membrane oxygenation. Early Hum Dev 1996;44:225-33.
21. 21. Graziani LJ, Baumgart S, Desai S, Stanley C, Gringlas M, Spitzer AR. Clinical antecedents of neurologic and audiologic abnormalities in survivors of neonatal extracorporeal membrane oxygenation. J Child Neurol 1997;12: 415-22.
22. 22. Robertson CM, Finer NN, Sauve RS, et al. Neurodevelopmental outcome after neonatal ECMO. CMAJ 1995; 152:1981-8.
23. 23. Graziani LJ, Gringlas M, Baumgart S. Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clin Perinatol 1997;24:655-76.
24. 24. Robertson CM, Cheung PY, Haluschak MM, Elliot, CA, Leonard NJ. High prevalence of sensorineural hearing loss among survivors of neonatal congenital diaphragmatic hernia. Western Canadian ECMO Follow-up Group. Am J Otol 1998;19:730-6.